Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics | 4 | 2024 | 4 | 2.450 |
Why?
|
| Drug Interactions | 4 | 2024 | 27 | 1.650 |
Why?
|
| Perioperative Period | 3 | 2024 | 4 | 1.630 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 11 | 1.410 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2021 | 19 | 1.410 |
Why?
|
| Chronic Disease | 2 | 2021 | 167 | 1.330 |
Why?
|
| Electrocardiography | 3 | 2023 | 36 | 1.010 |
Why?
|
| Laryngoscopes | 2 | 2016 | 2 | 0.970 |
Why?
|
| Humans | 33 | 2024 | 6794 | 0.910 |
Why?
|
| Plant Preparations | 1 | 2024 | 1 | 0.850 |
Why?
|
| Herb-Drug Interactions | 1 | 2024 | 1 | 0.850 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 85 | 0.730 |
Why?
|
| Pain, Postoperative | 8 | 2017 | 19 | 0.650 |
Why?
|
| Adult | 12 | 2023 | 2113 | 0.640 |
Why?
|
| Laryngoscopy | 2 | 2016 | 2 | 0.610 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 11 | 0.610 |
Why?
|
| Pain Measurement | 5 | 2017 | 51 | 0.560 |
Why?
|
| HIV Infections | 4 | 2016 | 432 | 0.510 |
Why?
|
| Postoperative Complications | 3 | 2016 | 109 | 0.490 |
Why?
|
| Video-Assisted Surgery | 1 | 2016 | 1 | 0.490 |
Why?
|
| Fiber Optic Technology | 1 | 2016 | 1 | 0.490 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 4 | 0.490 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 28 | 0.470 |
Why?
|
| Female | 17 | 2024 | 4060 | 0.460 |
Why?
|
| Betamethasone | 1 | 2015 | 4 | 0.460 |
Why?
|
| Steroids | 1 | 2015 | 8 | 0.460 |
Why?
|
| Low Back Pain | 1 | 2015 | 11 | 0.450 |
Why?
|
| Perioperative Care | 3 | 2024 | 5 | 0.450 |
Why?
|
| Middle Aged | 14 | 2017 | 2108 | 0.430 |
Why?
|
| United States | 3 | 2024 | 1019 | 0.430 |
Why?
|
| Obesity | 1 | 2016 | 226 | 0.400 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2016 | 9 | 0.400 |
Why?
|
| Analgesics, Opioid | 6 | 2016 | 58 | 0.390 |
Why?
|
| Male | 17 | 2024 | 3671 | 0.380 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 1 | 0.380 |
Why?
|
| Anesthesiology | 2 | 2024 | 3 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 64 | 0.370 |
Why?
|
| HIV-1 | 1 | 2012 | 36 | 0.370 |
Why?
|
| Clinical Competence | 2 | 2024 | 51 | 0.360 |
Why?
|
| Aged | 8 | 2017 | 1539 | 0.360 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2016 | 39 | 0.350 |
Why?
|
| Internship and Residency | 2 | 2024 | 62 | 0.350 |
Why?
|
| Prospective Studies | 6 | 2017 | 331 | 0.310 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2020 | 3 | 0.280 |
Why?
|
| Pain Management | 3 | 2016 | 27 | 0.270 |
Why?
|
| Equipment Design | 3 | 2016 | 20 | 0.270 |
Why?
|
| Anesthetics, Local | 2 | 2017 | 6 | 0.260 |
Why?
|
| Time Factors | 4 | 2016 | 321 | 0.260 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 16 | 0.250 |
Why?
|
| Anxiety | 2 | 2017 | 35 | 0.250 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 31 | 0.250 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 25 | 0.240 |
Why?
|
| Anesthesia, Conduction | 2 | 2016 | 4 | 0.240 |
Why?
|
| Phytotherapy | 1 | 2024 | 5 | 0.210 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 497 | 0.210 |
Why?
|
| Faculty, Medical | 1 | 2024 | 17 | 0.210 |
Why?
|
| Young Adult | 2 | 2016 | 567 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2024 | 44 | 0.200 |
Why?
|
| Heart | 1 | 2023 | 25 | 0.200 |
Why?
|
| Pneumothorax | 1 | 2022 | 2 | 0.190 |
Why?
|
| Retrospective Studies | 5 | 2016 | 681 | 0.190 |
Why?
|
| Educational Measurement | 1 | 2020 | 18 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2015 | 500 | 0.160 |
Why?
|
| Anesthetics, Intravenous | 2 | 2016 | 2 | 0.160 |
Why?
|
| Midazolam | 2 | 2016 | 3 | 0.160 |
Why?
|
| Adenosine | 2 | 2017 | 9 | 0.160 |
Why?
|
| Dexamethasone | 2 | 2017 | 30 | 0.150 |
Why?
|
| Double-Blind Method | 6 | 2017 | 101 | 0.150 |
Why?
|
| Anesthesia | 2 | 2016 | 8 | 0.140 |
Why?
|
| Intercostal Nerves | 1 | 2017 | 1 | 0.130 |
Why?
|
| Autonomic Nerve Block | 1 | 2017 | 2 | 0.130 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 5 | 0.130 |
Why?
|
| Interleukin-4 | 1 | 2017 | 9 | 0.130 |
Why?
|
| Hippocampus | 1 | 2017 | 19 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 17 | 0.130 |
Why?
|
| Facial Expression | 1 | 2017 | 1 | 0.130 |
Why?
|
| Manifest Anxiety Scale | 1 | 2017 | 1 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 9 | 0.130 |
Why?
|
| Preoperative Period | 1 | 2017 | 6 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 15 | 0.130 |
Why?
|
| Analgesia | 1 | 2016 | 16 | 0.130 |
Why?
|
| Preanesthetic Medication | 1 | 2016 | 1 | 0.130 |
Why?
|
| Propofol | 1 | 2016 | 3 | 0.130 |
Why?
|
| Mental Recall | 1 | 2016 | 3 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 7 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 3 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 5 | 0.120 |
Why?
|
| Immobilization | 1 | 2016 | 4 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2016 | 13 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 17 | 0.120 |
Why?
|
| Ritonavir | 1 | 2016 | 1 | 0.120 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 2 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 38 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 10 | 0.120 |
Why?
|
| Inflammation | 1 | 2017 | 143 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2016 | 34 | 0.120 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 28 | 0.120 |
Why?
|
| Heart, Artificial | 1 | 2015 | 1 | 0.110 |
Why?
|
| Injections, Epidural | 1 | 2015 | 1 | 0.110 |
Why?
|
| Sternotomy | 1 | 2015 | 1 | 0.110 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 2 | 0.110 |
Why?
|
| Ketamine | 1 | 2015 | 3 | 0.110 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2014 | 1 | 0.110 |
Why?
|
| Arthroplasty | 1 | 2014 | 1 | 0.110 |
Why?
|
| Prescription Drug Diversion | 1 | 2014 | 1 | 0.110 |
Why?
|
| Emergency Nursing | 1 | 2014 | 2 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 155 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 4 | 0.110 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 5 | 0.110 |
Why?
|
| Prescription Drug Misuse | 1 | 2014 | 2 | 0.110 |
Why?
|
| Fentanyl | 1 | 2014 | 7 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 1 | 0.110 |
Why?
|
| Spinal Puncture | 1 | 2014 | 1 | 0.110 |
Why?
|
| Myelography | 1 | 2014 | 3 | 0.110 |
Why?
|
| Spinal Diseases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 13 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 17 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 9 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 21 | 0.110 |
Why?
|
| Hypercapnia | 1 | 2014 | 1 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2014 | 8 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 24 | 0.110 |
Why?
|
| Cough | 2 | 2014 | 3 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 45 | 0.100 |
Why?
|
| Adolescent | 1 | 2016 | 869 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2024 | 82 | 0.100 |
Why?
|
| Viral Load | 1 | 2012 | 26 | 0.090 |
Why?
|
| Acupressure | 1 | 2012 | 1 | 0.090 |
Why?
|
| Disposable Equipment | 1 | 2012 | 2 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2012 | 21 | 0.090 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 1 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 5 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2011 | 8 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 9 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 1 | 0.080 |
Why?
|
| Ibuprofen | 1 | 2010 | 4 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2010 | 11 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2010 | 17 | 0.080 |
Why?
|
| Activities of Daily Living | 3 | 2020 | 19 | 0.080 |
Why?
|
| Animals | 4 | 2017 | 1875 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 1 | 2009 | 1 | 0.080 |
Why?
|
| Isoflurane | 1 | 2009 | 1 | 0.080 |
Why?
|
| Methyl Ethers | 1 | 2009 | 1 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 1 | 0.080 |
Why?
|
| Anesthesia, Inhalation | 1 | 2009 | 3 | 0.080 |
Why?
|
| Health Personnel | 2 | 2022 | 49 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2016 | 280 | 0.070 |
Why?
|
| Antiemetics | 2 | 2020 | 3 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 193 | 0.060 |
Why?
|
| Dogs | 2 | 2017 | 18 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 7 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 112 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2024 | 3 | 0.050 |
Why?
|
| Feedback | 1 | 2024 | 12 | 0.050 |
Why?
|
| Decision Making | 1 | 2024 | 25 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 28 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 231 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 87 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 42 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 7 | 0.040 |
Why?
|
| Checklist | 1 | 2020 | 2 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 8 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 27 | 0.040 |
Why?
|
| Los Angeles | 2 | 2012 | 321 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 9 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 5 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 5 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 9 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 84 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 98 | 0.030 |
Why?
|
| Pain, Procedural | 1 | 2016 | 1 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 3 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Aging | 1 | 2017 | 105 | 0.030 |
Why?
|
| Hospitals | 1 | 2016 | 17 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 282 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2016 | 5 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 22 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 15 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 28 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 2 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 2 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 2 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 5 | 0.030 |
Why?
|
| Professional Misconduct | 1 | 2014 | 3 | 0.030 |
Why?
|
| Spinal Cord Compression | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 285 | 0.030 |
Why?
|
| Myocardium | 1 | 2014 | 25 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 112 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 8 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 24 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 58 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 108 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2014 | 6 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 45 | 0.030 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 8 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 50 | 0.030 |
Why?
|
| Recurrence | 1 | 2014 | 55 | 0.030 |
Why?
|
| Oximetry | 1 | 2014 | 1 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 6 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 127 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 506 | 0.030 |
Why?
|
| Ondansetron | 1 | 2012 | 1 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 2012 | 2 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 33 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 767 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2011 | 4 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 3 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 24 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 9 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 21 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2011 | 16 | 0.020 |
Why?
|
| Celecoxib | 1 | 2010 | 1 | 0.020 |
Why?
|
| Italy | 1 | 2010 | 2 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2010 | 5 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 11 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 54 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 258 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 746 | 0.020 |
Why?
|